Biocon Q4FY22 revenue at Rs 2,476 crores, up 21 per cent
FY22 revenue at Rs 8,397 crores, up 14 per cent; core EBITDA up 18 per cent at Rs 2,669 crores; PBT (before Exceptional Item) at…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biocon financial results
Biocon’s consolidated Q3FY22 revenue grows by 18 per cent YoY to Rs 2,223 crores
Biosimilars up by 28 per cent at Rs 981 crores; research services up by 10 per cent at Rs 641 crores and generics up by seven per…